Literature DB >> 22855291

The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS).

Yuri A Saito1, Joseph J Larson, Elizabeth J Atkinson, Euijung Ryu, Ann E Almazar, Gloria M Petersen, Nicholas J Talley.   

Abstract

BACKGROUND: Smaller studies have evaluated SLC6A4 5-HTTLPR and GNβ3 825C>T polymorphisms in IBS, and interactions between 5-HTT LPR with life events have been reported in the psychiatric literature, but gene-environment studies in IBS are lacking. AIMS: The purpose of this study was to assess the association of two polymorphisms with IBS and age of onset, and whether there are gene-environment interactions with IBS.
METHODS: Outpatients with IBS and controls completed a validated questionnaire and provided blood for DNA. Comparisons of genotype/allele frequencies between cases and controls were performed with logistic regression. Linear regression was used to evaluate the association between the variants and age of onset. Environmental variables tested included abuse, parental alcohol abuse, parental psychiatric disorders, and gastrointestinal infections.
RESULTS: Genotyping was performed in 385 cases and 262 controls with median age of 50 years (range, 18.0-70.0) and 498 (77 %) females. The IBS subtype distribution among cases was: 102 (26 %) D-IBS, 40 (10 %) C-IBS, 125 (32 %) M-IBS, 118 (31 %) other. No association was observed between IBS or age of onset and both variants. Significant interactions were observed between GI infection and the GNβ3 825T allele. For those reporting gastrointestinal infection, the OR for IBS was 3.9 (95 % CI 1.2-12.7) whereas the OR was 0.86 (95 % CI 0.65-1.13) for those without prior infection.
CONCLUSIONS: There was a significant interaction between the GNβ3 polymorphism and infection in the development of IBS, suggesting that its etiology is the result of a combination of specific genetic and environmental risk factors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855291      PMCID: PMC3912694          DOI: 10.1007/s10620-012-2319-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study.

Authors:  Gregory C Gray; Robert J Reed; Kevin S Kaiser; Tyler C Smith; Victor M Gastañaga
Journal:  Am J Epidemiol       Date:  2002-06-01       Impact factor: 4.897

Review 2.  Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

Authors:  William E Whitehead; Olafur Palsson; Kenneth R Jones
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

3.  Psychometric properties of the SUNYA revision of the Psychosomatic Symptom Checklist.

Authors:  V Attanasio; F Andrasik; E B Blanchard; J G Arena
Journal:  J Behav Med       Date:  1984-06

4.  Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology.

Authors:  R L Levy; K R Jones; W E Whitehead; S I Feld; N J Talley; L A Corey
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

5.  Family study of affective spectrum disorder.

Authors:  James I Hudson; Barbara Mangweth; Harrison G Pope; Christine De Col; Armand Hausmann; Sarah Gutweniger; Nan M Laird; Wilfried Biebl; Ming T Tsuang
Journal:  Arch Gen Psychiatry       Date:  2003-02

6.  Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome.

Authors:  Michael Camilleri; Elena Atanasova; Paula J Carlson; Umraan Ahmad; H Jae Kim; Blanca E Viramontes; Sanna McKinzie; Raul Urrutia
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

7.  G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia.

Authors:  Gerald Holtmann; Winfried Siffert; Sebastian Haag; Norbert Mueller; Mathias Langkafel; Wolfgang Senf; Rainer Zotz; Nicholas J Talley
Journal:  Gastroenterology       Date:  2004-04       Impact factor: 22.682

8.  Non-colonic features of irritable bowel syndrome.

Authors:  P J Whorwell; M McCallum; F H Creed; C T Roberts
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

9.  The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology.

Authors:  R Haringsma; G I Engels; A T F Beekman; Ph Spinhoven
Journal:  Int J Geriatr Psychiatry       Date:  2004-06       Impact factor: 3.485

10.  Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders.

Authors:  H-J Lee; J-H Cha; B-J Ham; C-S Han; Y-K Kim; S-H Lee; S-H Ryu; R-H Kang; M-J Choi; M-S Lee
Journal:  Pharmacogenomics J       Date:  2004       Impact factor: 3.550

View more
  14 in total

Review 1.  Genetic approaches to functional gastrointestinal disorders.

Authors:  Yuri A Saito; Nandita Mitra; Emeran A Mayer
Journal:  Gastroenterology       Date:  2010-02-19       Impact factor: 22.682

Review 2.  Genetic polymorphism in pathogenesis of irritable bowel syndrome.

Authors:  Cynthia K Y Cheung; Justin C Y Wu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

3.  Identification of putative transcriptomic biomarkers in irritable bowel syndrome (IBS): Differential gene expression and regulation of TPH1 and SERT by vitamin D.

Authors:  Aleksandra Grozić; Keaton Coker; Christopher M Dussik; Marya S Sabir; Zhela Sabir; Arianna Bradley; Lin Zhang; Jin Park; Steven Yale; Ichiro Kaneko; Maryam Hockley; Lucinda A Harris; Tisha N Lunsford; Todd R Sandrin; Peter W Jurutka
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 4.  Molecular basis of the irritable bowel syndrome.

Authors:  Anna Vaiopoulou; Georgios Karamanolis; Theodora Psaltopoulou; George Karatzias; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

5.  New paradigm for studying genetic contributions to irritable bowel syndrome.

Authors:  Miranda A L van Tilburg; William E Whitehead
Journal:  Dig Dis Sci       Date:  2012-10       Impact factor: 3.199

6.  No association of G-protein beta polypeptide 3 polymorphism with irritable bowel syndrome: evidence from a meta-analysis.

Authors:  Zhi-Gang Pan; Chen Xiao; Dong-Xing Su
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

7.  Celiac disease is uncommon in irritable bowel syndrome in the USA.

Authors:  Ann E Almazar; Nicholas J Talley; Joseph J Larson; Elizabeth J Atkinson; Joseph A Murray; Yuri A Saito
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 2.566

Review 8.  Genetic epidemiology of irritable bowel syndrome.

Authors:  Jasbir Makker; Sridhar Chilimuri; Jonathan N Bella
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

Review 9.  Irritable bowel syndrome: emerging paradigm in pathophysiology.

Authors:  Yoo Jin Lee; Kyung Sik Park
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 10.  The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies.

Authors:  Zhi-Feng Zhang; Zhi-Jun Duan; Li-Xia Wang; Dong Yang; Gang Zhao; Lin Zhang
Journal:  BMC Gastroenterol       Date:  2014-02-10       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.